Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance

Liver Transplantation

Volumn 18, Issue 4, 2012, Pages 444-454

  Xie, Lin ^a,b   Ichimaru, Naotsugu ^b   Morita, Miwa ^c   Chen, Jiajie ^a,d   Zhu, Ping ^a   Wang, Jihong ^e   Urbanellis, Peter ^e   Shalev, Itay ^e   Nagao, Shizuko ^c   Sugioka, Atsushi ^c   Zhong, Liang ^d   Nonomura, Norio ^b   Takahara, Shiro ^b   Levy, Gary A ^e   Li, Xiao Kang ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d FUDAN UNIVERSITY   (China)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CD39 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FIBRINOGEN; FIBRINOGEN LIKE PROTEIN 2; GAMMA INTERFERON; GRANZYME B; LECTIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR G1; PHOSPHODIESTERASE 3B; PHOSPHODIESTERASE III; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN KLRG1; SELECTIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIAC GRAFT REJECTION; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; GENE EXPRESSION; HEART TRANSPLANTATION; HOUSEKEEPING GENE; IMMUNOREGULATION; LIVER GRAFT REJECTION; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANIMALS; GENE EXPRESSION PROFILING; GENETIC MARKERS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INFLAMMATION MEDIATORS; LIVER TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIROLIMUS; TIME FACTORS; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 84859301176     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22480     Document Type: Article

References (36)

1. Moore DJ, Markmann JF, Deng S. Avenues for immunomodulation and graft protection by gene therapy in transplantation. Transpl Int 2006;19:435-445. (Pubitemid 43736339)
2. Einecke G, Reeve J, Sis B, Mengel M, Hidalgo L, Famulski KS, et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010;120:1862-1872.
3. Al-Awwa IA, Hariharan S, First MR. Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis. Am J Kidney Dis 1998;31(suppl 1):S15-S18. (Pubitemid 28265211)
4. Mansfield ES, Sarwal MM. Arraying the orchestration of allograft pathology. Am J Transplant 2004;4:853-862. (Pubitemid 38745583)
5. Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Deng MC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Elashoff B, Baron H, Yee J, Valantine HA; for IMAGE Study Group. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med 2010;362:1890-1900.
6. Kurian SM, Heilman R, Mondala TS, Nakorchevsky A, Hewel JA, Campbell D, et al. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One 2009;4:e6212.
7. Khatri P, Sarwal MM. Using gene arrays in diagnosis of rejection. Curr Opin Organ Transplant 2009;14:34-39.
8. Kurian S, Grigoryev Y, Head S, Campbell D, Mondala T, Salomon DR. Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers. Int Immunopharmacol 2007;7:1948-1960. (Pubitemid 350138518)
9. Strom TB, Suthanthiran M. Prospects and applicability of molecular diagnosis of allograft rejection. Semin Nephrol 2000;20:103-107. (Pubitemid 30158480)
10. Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol 2010;28:486-494.
11. Warnock DG, Peck CC. A roadmap for biomarker qualification. Nat Biotechnol 2010;28:444-445.
12. Rai AJ, Kamath RM, Gerald W, Fleisher M. Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling. Anal Bioanal Chem 2009;393:1505-1511.
13. Morita M, Fujino M, Jiang G, Kitazawa Y, Xie L, Azuma M, et al. PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant 2010;10:40-46.
14. Morita M, Fujino M, Li XK, Kimura H, Nakayama T, Taniguchi M, Sugioka A. Spontaneous tolerance involving natural killer T cells after hepatic grafting in mice. Transpl Immunol 2007;18:142-145. (Pubitemid 350086962)
15. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658-663.
16. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24:1710-1720. (Pubitemid 41641841)
17. Chan CW, Kay LS, Khadaroo RG, Chan MW, Lakatoo S, Young KJ, et al. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol 2003;170:4036-4044. (Pubitemid 36428165)
18. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, Rudensky AY. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007;445:771-775. (Pubitemid 46279714)
19. Vivier E, Romagné F. Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion. Immunity 2007;26:549-551. (Pubitemid 46756358)
20. Laderach DJ, Compagno D, Toscano MA, Croci DO, Dergan-Dylon S, Salatino M, Rabinovich GA. Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings. IUBMB Life 2010;62:1-13.
21. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353:2342-2351. (Pubitemid 41713746)
22. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007;148:32-46. (Pubitemid 46365005)
23. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007;204:1257-1265. (Pubitemid 46919862)
24. + regulatory T cells in vivo. J Immunol 2006;177:209-215.
25. Nocentini G, Ronchetti S, Cuzzocrea S, Riccardi C. GITR/GITRL: more than an effector T cell co-stimulatory system. Eur J Immunol 2007;37:1165-1169. (Pubitemid 46925300)
26. Tordjman R, Lepelletier Y, Lemarchandel V, Cambot M, Gaulard P, Hermine O, Roméo PH. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 2002;3:477-482. (Pubitemid 34520798)
27. Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family? Immunol Rev 2008;226:248-262.
28. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008;358:353-361. (Pubitemid 351159234)
29. Nadig SN, Wieckiewicz J, Wu DC, Warnecke G, Zhang W, Luo S, et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 2010;16:809-813.
30. Tamura S, Sugawara Y. Perspectives on liver transplantation in the People's Republic of China. Biosci Trends 2007;1:5-6.
31. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol 2003;4:1169-1176. (Pubitemid 37540685)
32. Smith GW, Rosa GJ. Interpretation of microarray data: trudging out of the abyss towards elucidation of biological significance. J Anim Sci 2007;85(suppl):E20-E23.
33. + regulatory T cells. Am J Transplant 2008;8:1639-1651.
34. Yang HR, Chou HS, Gu X, Wang L, Brown KE, Fung JJ, et al. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferongamma signaling. Hepatology 2009;50:1981-1991.
35. Millán O, Benitez C, Guillén D, López A, Rimola A, Sánchez- Fueyo A, Brunet M. Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy. Clin Immunol 2010;137:337-346.
36. Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008;118:2845-2857.